chitosan has been researched along with Chronic Disease in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (3.70) | 18.2507 |
2000's | 3 (11.11) | 29.6817 |
2010's | 18 (66.67) | 24.3611 |
2020's | 5 (18.52) | 2.80 |
Authors | Studies |
---|---|
Jain, P; Kulkarni, N; Shindikar, A; Suryawanshi, P; Thorat, N | 1 |
Gong, Z; Liu, R | 1 |
Brar, T; Brown, A; Lal, D; Marino, MJ; Miglani, A | 1 |
Chen, Q; Li, Y; Liu, Y; Pan, H; Qi, W; Wong, TM; Wu, J; Yeung, KWK; Zhang, C; Zhao, X | 1 |
Argenziano, M; Basilico, N; Cavalli, R; Costa, E; D'Alessandro, S; Delbue, S; Mazzaccaro, D; Nano, G; Prato, M; Ticozzi, R | 1 |
Adachi, T; Anraku, M; Hirayama, F; Iohara, D; Kawano, K; Maezaki, Y; Mizukai, Y; Okazaki, S; Otagiri, M; Takeshita, K | 1 |
Chen, W; Dai, X; Shi, G; Wu, Z; Zhang, X; Zhang, Y | 1 |
Huang, TW; Li, ST; Young, TH | 1 |
Pawar, V; Srivastava, R | 1 |
Beenken, KE; Bellamy, W; Gruenwald, MJ; Haggard, WO; Jennings, JA; Mclaren, SG; Skinner, RA; Smeltzer, MS; Smith, JK; Spencer, HJ | 1 |
Dreifke, MB; Jayasuriya, AA; Jayasuriya, AC | 1 |
Kerch, G | 1 |
Chai, D; Dong, C; Xiong, S; Xu, W; Yue, Y | 1 |
Cao, C; Hu, Z; Yan, C; Zhou, S | 1 |
Choi, SJ; Choung, PH; Choung, YH; Chung, JH; Kim, JH; Kim, SW; Lee, JB; Lim, KT; Park, JS | 1 |
Li, X; Li, Y; Liu, H; Morsi, YS; Shi, P; Zhang, L; Zou, Q; Zuo, Y | 1 |
Day, DE; Huang, WH; Jia, WT; Liu, X; Luo, SH; Rahaman, MN; Wang, JQ; Xie, ZP; Zhang, CQ; Zhang, X | 1 |
Day, DE; Gu, Y; Huang, W; Jia, W; Liu, X; Rahaman, MN; Wang, D; Xiao, W; Zhang, C; Zhang, X; Zhou, N | 1 |
Chacko, AJ; Jose, S; Prema, MT; Souto, EB; Thomas, AC | 1 |
Fan, X; Huang, J; Ma, T; Tang, H; Xu, Y | 1 |
Chatsudthipong, V; Muanprasat, C; Pichyangkura, R; Soodvilai, S; Yousef, M | 1 |
Das, S; Medina, JG | 1 |
Eckl, S; Ensminger, SM; Goldmann, K; Hoffmann, J; Spriewald, BM | 1 |
Akncbay, H; Ay, ZY; Senel, S | 1 |
Chiang, CE; Huang, SS; Sung, SH | 1 |
Athanasiadis, T; Beule, AG; Robinson, BH; Robinson, SR; Shi, Z; Wormald, PJ | 1 |
Bao, J; Chen, A; Hou, C | 1 |
4 review(s) available for chitosan and Chronic Disease
Article | Year |
---|---|
Advances in the colon-targeted chitosan based multiunit drug delivery systems for the treatment of inflammatory bowel disease.
Topics: Chitosan; Chronic Disease; Colon; Drug Carriers; Drug Delivery Systems; Humans; Inflammatory Bowel Diseases; Polymers | 2022 |
Effect of chitosan-based gel dressing on wound infection, synechia, and granulations after endoscopic sinus surgery of nasal polyps: A meta-analysis.
Topics: Bandages; Chitosan; Chronic Disease; Humans; Nasal Polyps; Paranasal Sinuses; Wound Infection | 2022 |
Current wound healing procedures and potential care.
Topics: Acute Disease; Biological Dressings; Cell- and Tissue-Based Therapy; Cellular Microenvironment; Chitosan; Chronic Disease; Collagen; Humans; Hyaluronic Acid; Intercellular Signaling Peptides and Proteins; MicroRNAs; RNA, Small Interfering; Silicon; Wound Healing; Wounds and Injuries | 2015 |
The potential of chitosan and its derivatives in prevention and treatment of age-related diseases.
Topics: Aging; Animals; Chitosan; Chronic Disease; Dietary Supplements; Foods, Specialized; Humans; Oligosaccharides; Oxidative Stress | 2015 |
2 trial(s) available for chitosan and Chronic Disease
Article | Year |
---|---|
Sprayable chitosan/starch-based sealant reduces adhesion formation in a sheep model for chronic sinusitis.
Topics: Animals; Chitosan; Chronic Disease; Disease Models, Animal; Endoscopy; Paranasal Sinuses; Postoperative Complications; Prospective Studies; Rhinitis; Sheep; Sinusitis; Starch; Tissue Adhesions | 2013 |
Application of chitosan gel in the treatment of chronic periodontitis.
Topics: Adult; Anti-Infective Agents, Local; Biocompatible Materials; Chitosan; Chronic Disease; Dental Materials; Drug Carriers; Female; Gels; Humans; Male; Materials Testing; Metronidazole; Middle Aged; Periodontitis | 2007 |
21 other study(ies) available for chitosan and Chronic Disease
Article | Year |
---|---|
Outcomes of Frontal Sinus Stenting With Steroid Impregnated Microsponge Versus Steroid-Eluting Implant.
Topics: Chitosan; Chronic Disease; Endoscopy; Frontal Sinus; Humans; Rhinitis; Sinusitis; Stents; Steroids; Treatment Outcome; Triamcinolone | 2023 |
Electrospun chitosan/PVA/bioglass Nanofibrous membrane with spatially designed structure for accelerating chronic wound healing.
Topics: Animals; Bandages; Cell Line; Ceramics; Chitosan; Chronic Disease; Diabetes Complications; Diabetes Mellitus, Experimental; Male; Membranes, Artificial; Mice; Nanofibers; Polyvinyl Alcohol; Rats; Rats, Sprague-Dawley; Wound Healing; Wounds and Injuries | 2019 |
Effect of antibiotic-loaded chitosan nanodroplets on
Topics: Anti-Bacterial Agents; Chitosan; Chronic Disease; Drug Carriers; Enterococcus; Humans; Lower Extremity; Microbial Sensitivity Tests; Nanostructures; Oxygen; Ulcer; Vancomycin | 2020 |
The preparation and validation of chitosan tablets that rapidly disperse and disintegrate as an oral adsorbent in the treatment of lifestyle-related diseases.
Topics: Administration, Oral; Adsorption; Animals; Chitosan; Chronic Disease; Crystallization; Drug Carriers; Gastrointestinal Tract; Life Style; Magnetic Resonance Imaging; Male; Powders; Rats; Rats, Wistar; Sorption Detoxification; Tablets; Temperature; Water | 2021 |
An Antifouling Hydrogel Containing Silver Nanoparticles for Modulating the Therapeutic Immune Response in Chronic Wound Healing.
Topics: Animals; Anti-Bacterial Agents; Chitosan; Chronic Disease; Dermis; Dextrans; Diabetes Mellitus, Experimental; Hydrogels; Male; Metal Nanoparticles; Mice; NIH 3T3 Cells; Pseudomonas aeruginosa; Rats, Sprague-Dawley; Silver; Skin Ulcer; Staphylococcus aureus; T-Lymphocytes; Wound Healing | 2019 |
Chitosan-hyaluronan: promotion of mucociliary differentiation of respiratory epithelial cells and development of olfactory receptor neurons.
Topics: Cell Differentiation; Cells, Cultured; Chitosan; Chronic Disease; Humans; Hyaluronic Acid; Nasal Mucosa; Olfactory Receptor Neurons; Rhinitis; Signal Transduction | 2019 |
Chitosan-polycaprolactone blend sponges for management of chronic osteomyelitis: A preliminary characterization and in vitro evaluation.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Biocompatible Materials; Cell Line; Cell Survival; Chitosan; Chronic Disease; Ciprofloxacin; Drug Delivery Systems; Drug Liberation; Erythrocytes; Humans; Ibuprofen; Mice; Osteomyelitis; Polyesters; Staphylococcus aureus | 2019 |
Chitosan coating to enhance the therapeutic efficacy of calcium sulfate-based antibiotic therapy in the treatment of chronic osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Calcium Sulfate; Chitosan; Chronic Disease; Coated Materials, Biocompatible; Daptomycin; Disease Models, Animal; Drug Delivery Systems; Male; Materials Testing; Osteomyelitis; Polymethyl Methacrylate; Prosthesis-Related Infections; Rabbits; Staphylococcal Infections | 2014 |
AIM2 co-immunization favors specific multifunctional CD8(+) T cell induction and ameliorates coxsackievirus B3-induced chronic myocarditis.
Topics: Administration, Intranasal; Animals; CD8-Positive T-Lymphocytes; Chitosan; Chronic Disease; Coxsackievirus Infections; Cytokines; Disease Models, Animal; DNA-Binding Proteins; Intestinal Mucosa; Mice, Inbred BALB C; Myocarditis; Myocardium; Vaccination; Vaccines, DNA | 2015 |
Potential application of injectable chitosan hydrogel treated with siRNA in chronic rhinosinusitis therapy.
Topics: Animals; Bronchi; Cell Line; Chitosan; Chronic Disease; Delayed-Action Preparations; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Male; Rats, Sprague-Dawley; RNA, Small Interfering; RNAi Therapeutics; Sinusitis; Vascular Endothelial Growth Factor A | 2015 |
Tympanic membrane regeneration using a water-soluble chitosan patch.
Topics: Absorbable Implants; Animals; Chitosan; Chronic Disease; Humans; Materials Testing; Otitis Media; Rats; Rats, Sprague-Dawley; Regeneration; Solubility; Tympanic Membrane; Tympanic Membrane Perforation | 2010 |
Gentamicin-impregnated chitosan/nanohydroxyapatite/ethyl cellulose microspheres granules for chronic osteomyelitis therapy.
Topics: Animals; Cell Death; Cell Survival; Cellulose; Chitosan; Chronic Disease; Durapatite; Fibroblasts; Gentamicins; Humans; Implants, Experimental; Microspheres; Nanostructures; Osteoblasts; Osteomyelitis; Rabbits; Radiography; Rats; Rats, Wistar; Staphylococcus aureus; Tibia | 2010 |
Novel borate glass/chitosan composite as a delivery vehicle for teicoplanin in the treatment of chronic osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Bone Substitutes; Borates; Chitosan; Chronic Disease; Diffusion; Drug Implants; Glass; Materials Testing; Osteomyelitis; Rabbits; Teicoplanin; Treatment Outcome | 2010 |
Teicoplanin-loaded borate bioactive glass implants for treating chronic bone infection in a rabbit tibia osteomyelitis model.
Topics: Animals; Anti-Bacterial Agents; Borates; Chitosan; Chronic Disease; Drug Implants; Female; Glass; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Rabbits; Staphylococcal Infections; Teicoplanin; Tibia | 2010 |
Colon specific chitosan microspheres for chronotherapy of chronic stable angina.
Topics: Angina Pectoris; Animals; Chitosan; Chronic Disease; Colon; Diltiazem; Drug Chronotherapy; Drug Delivery Systems; Hydrogen-Ion Concentration; Microspheres; Particle Size; Polymethacrylic Acids; Rats; Rats, Wistar | 2011 |
[Vancomycin cationic liposome combined with nano-hydroxyapatite/chitosan/konjac glucomannan scaffold for treatment of infected bone defects in rabbits].
Topics: Animals; Bone Diseases; Bone Regeneration; Chitosan; Chronic Disease; Durapatite; Liposomes; Mannans; Nanostructures; Osteomyelitis; Rabbits; Staphylococcal Infections; Tissue Scaffolds; Vancomycin | 2012 |
Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Topics: Acetic Acid; Acute Disease; Administration, Oral; Animals; Anti-Inflammatory Agents; Apoptosis; Cell Line; Chitosan; Chronic Disease; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Gastrointestinal Agents; Humans; Inflammation Mediators; Inflammatory Bowel Diseases; Interleukin-6; Intestinal Mucosa; Male; Mice; Mice, Inbred ICR; NF-kappa B; Oxidative Stress; Permeability; Reactive Oxygen Species; Signal Transduction; Time Factors; Tumor Necrosis Factor-alpha | 2012 |
Attenuation of transplant arteriosclerosis by oral feeding of major histocompatibility complex encoding chitosan-DNA nanoparticles.
Topics: Administration, Oral; Animals; Arteriosclerosis Obliterans; Benzofurans; Chitosan; Chronic Disease; DNA; Graft Rejection; Heart Transplantation; Isoantigens; Major Histocompatibility Complex; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Nanoparticles; Postoperative Complications; Quinolines; Transplantation Tolerance; Treatment Outcome | 2013 |
Chitosan potentiation of warfarin effect.
Topics: Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Chitosan; Chronic Disease; Diabetes Mellitus, Type 2; Drug Synergism; Humans; Hypertension; International Normalized Ratio; Male; Self Medication; Thrombosis; Vitamin K; Vitamins; Warfarin | 2007 |
Effects of a novel chitosan gel on mucosal wound healing following endoscopic sinus surgery in a sheep model of chronic rhinosinusitis.
Topics: Animals; Biocompatible Materials; Chitosan; Chronic Disease; Dextrans; Disease Models, Animal; Endoscopy; Epithelium; Gels; Mucous Membrane; Polyethylene Glycols; Postoperative Complications; Random Allocation; Recombinant Proteins; Sheep; Sinusitis; Thromboplastin; Tissue Adhesions; Wound Healing | 2008 |
[Clinical study of gentamycin-loaded chitosan drug delivery system].
Topics: Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Chitin; Chitosan; Chronic Disease; Drug Carriers; Drug Delivery Systems; Female; Follow-Up Studies; Gentamicins; Humans; Male; Middle Aged; Osteomyelitis | 1998 |